68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.110.075002
Full Text
Open PDFAbstract
Available in full text
Date
August 18, 2010
Authors
Publisher
Society of Nuclear Medicine